In persons at intermediate risk for CVD, polypills reduce a composite of CV events at 5 y
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j21-0004
Abstract: SOURCE CITATION Joseph P, Roshandel G, Gao P, et al. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis. Lancet. 2021;398:1133-46. 34469765. read more here.
Keywords: polypills reduce; persons intermediate; intermediate risk; risk cvd ... See more keywords